3D Systems Corporation (DDD) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects a negative sentiment due to a significant revenue decline, reduced gross margins, and a net loss. Despite some cost-cutting improvements and new partnerships, the lack of clear guidance on achieving breakeven and the unclear management responses in the Q&A section contribute to investor uncertainty. The positive developments in the dental market and new partnerships are overshadowed by the overall financial performance and market concerns, leading to a likely negative stock price reaction.
Key Financial Performance
Revenue Third quarter revenue was $91.2 million, down 13.8% year-over-year. The decline was attributed to customers' muted CapEx spending for new production capacity due to uncertainty around tariffs.
Industrial Solutions Revenue Revenue of $48 million declined 16% year-over-year or 4.5% excluding Geomagic. The decline was driven by softness in printers and materials sales in consumer-facing end markets, partially offset by nearly 50% growth in aerospace and defense.
Healthcare Solutions Revenue Revenue of $43 million decreased 22% from the prior year, predominantly due to lower sales within dental, with 2024 representing higher purchase volumes from a specific customer. MedTech delivered 8% growth from the prior year and slightly ahead of last quarter.
Gross Margin Non-GAAP gross margin for the third quarter was 33%, compared to 38% in the prior year and 34% when adjusted to exclude Geomagic. The decline was driven by lower sales volume and reduced material sales, partially offset by reduced inventory reserves.
Operating Expenses Non-GAAP operating expenses were $44.7 million, down 24% year-over-year when adjusted to exclude Geomagic and down 4.5% sequentially. This reflects the impact of cost reduction initiatives aimed at optimizing organizational capacity and reducing expenses.
Adjusted EBITDA Adjusted EBITDA for the third quarter was negative $10.8 million, an improvement of $3.5 million compared to the prior year. This reflects progress in cost reductions across the business.
Net Loss GAAP net loss for the quarter was $18 million or $0.14 per share, an improvement compared to the $1.35 loss per share in the prior year period. The improvement was due to the absence of prior year asset impairment charges, lower amortization expense, and reduced operating expenses.
Cash Position The company closed the quarter with $114 million in total cash, consisting of $95 million in cash and cash equivalents and $19 million in restricted cash. Total debt net of deferred financing costs was $123 million.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
MJP 300W Plus Printer: Launched at the Istanbul Jewelry Show, this printer improves productivity by 30% and reduces precious metal waste by 20%. It targets the global jewelry market, which is transitioning to digital manufacturing.
NextDent Jetted Denture Solution: Released for the U.S. market, this solution offers a faster, cost-effective alternative to traditional denture manufacturing. It is expected to drive significant growth in the dental market, with a potential $1 billion industry revenue in the U.S. and Europe.
Saudi Arabian Growth Initiative: Partnership with NAMI and Saudi Electric Company to support Saudi Arabia's Vision 2030. Includes a $26 million agreement for manufacturing tungsten core components and collaboration with Lockheed Martin for aerospace and defense applications.
AI Infrastructure and Aerospace/Defense: Investments in semiconductor manufacturing, data centers, and aerospace/defense applications. Focus on 3D printing for critical components in these high-growth sectors.
Cost Reduction Initiatives: Achieved $50 million in annualized savings by year-end 2025 through organizational optimization, facility streamlining, and expense reduction.
Divestiture of Non-Core Assets: Sale of Oqton and 3DXpert software platforms to focus on core R&D investments and long-term growth.
Focus on MedTech: Emphasis on personalized health services, medical implants, and regulatory-approved 3D printing applications. Growth driven by innovations like printed PEEK materials for medical use.
Strategic Investments in Core Assets: Continued investment in metal and polymer printing technologies to drive future growth and profitability.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Revenue Decline: Third quarter revenue was $91.2 million, down 13.8% year-over-year, reflecting challenges in the macro environment and muted customer CapEx spending due to tariff uncertainties.
Cost Structure Adjustments: Aggressive cost-cutting measures are being implemented to address revenue softness, but these may impact operational flexibility and long-term investments.
Divestiture of Non-Core Assets: The sale of Oqton and 3DXpert software platforms will reduce Q4 revenue by $1.2 million and gross margin by $1 million, potentially impacting short-term financial performance.
Market Competition: The global jewelry market is highly competitive, posing challenges for the adoption of new 3D printing technologies.
Regulatory Approvals: Delays in regulatory approvals for dental products in Europe and other regions could hinder market expansion and revenue growth.
Economic Uncertainty: Uncertainty around tariffs and broader economic conditions continues to suppress customer spending on new production capacity.
Seasonality and Demand Fluctuations: Seasonal demand fluctuations, particularly in MedTech and dental markets, create revenue volatility.
Debt Obligations: The company has $123 million in total debt, with $35 million due in 2026, which could strain financial resources if revenue challenges persist.
Operational Risks in Saudi Arabia: The Saudi Arabian Growth Initiative requires significant local capabilities and partnerships, which may take time to fully establish and yield results.
AI and Aerospace Investments: While promising, investments in AI infrastructure and aerospace/defense markets are still in early stages and may not yield immediate returns.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Q4 Financial Impact: The financial impact of the sale of Oqton and 3DXpert on Q4 results is expected to be approximately $1.2 million in revenue and $1 million on gross margin.
Metal and Polymer Printing Technology: Strategic investments in R&D for metal and polymer printing technology are expected to drive future growth and profitability.
MJP 300W Plus Printer: The new printer platform, launched in the jewelry market, is expected to improve productivity by 30% and reduce waste by 20%. Orders have already been accepted, and growth is anticipated in the coming quarters.
NextDent Jetted Denture Solution: The U.S. market launch has been successful, with European regulatory approval targeted for mid-2026. The market opportunity is expected to reach $1 billion in industry revenue across the U.S. and Europe over the next several years.
MedTech Growth: The MedTech business is on track to grow at a double-digit rate this year, driven by new applications, materials, and printing technologies.
Saudi Arabian Growth Initiative: The initiative is expected to contribute significantly to global growth strategy in high-reliability industrial markets in future years, with partnerships in energy, defense, and aerospace sectors.
AI Infrastructure and Aerospace/Defense: These emerging growth opportunities are expected to benefit from significant investments, with applications in semiconductor manufacturing, data centers, and gas turbine engines.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What caused the decline in gross margins this quarter?
A:The decline in gross margins was due to two main factors: a $2 million milestone recognized under the lung program in the prior quarter and manufacturing variances, including scrap and inventory reserves for slower-moving inventory. These factors are not expected to repeat going forward.
Q:Is there more to do on cost-cutting efforts, and what revenue level is needed to achieve breakeven?
A:There is still some work left on cost-cutting, particularly with facility consolidations, which are expected to be completed in the first part of next year. The company aims to achieve $70 million in cost takeouts, which, in a normalized environment, should lead to positive cash flow and profitability. However, this is dependent on sales volume and gross margin.
Q:Can you provide more details about the new partnerships with Lockheed Martin and initiatives in the Middle East?
A:The company works with Lockheed Martin globally, including in the U.S. and Saudi Arabia. The Saudi initiative aligns with local manufacturing and innovation requirements tied to defense spending. Specific details about the products and systems cannot be disclosed, but they include aircraft and missile systems.
Q:What are the CapEx expectations for the next year?
A:CapEx is expected to be significantly lower than the historical average of 4% of sales due to prior investments in infrastructure. For the next couple of years, CapEx could be less than half of the historical benchmark.
Q:What is driving the stabilization of the Dental business, and what is the opportunity with monolithic dentures?
A:The Dental business stabilization is driven by consistent performance in materials for teeth repair and a stabilizing aligner market. The opportunity with monolithic dentures lies in their ability to replace labor-intensive manufacturing with 3D printing, offering significant time and cost savings. Regulatory approvals in Europe and other regions are expected by 2026, with strong market acceptance anticipated.
Q:Will the denture initiative provide a more stable revenue stream?
A:Yes, dentures are considered essential items, particularly for aging populations. The initiative is expected to provide a stable and growing revenue stream as manufacturing transitions to 3D printing and demand increases.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the specific revenue level needed to achieve breakeven, citing dependencies on sales volume and gross margin. Additionally, details about the products and systems in the Lockheed Martin partnership were not disclosed due to confidentiality.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Arabian
Asia
Interim CFO
MedTech health
NAMI
OEMs
PEEK
Saudi Arabia
Slide core
adoption
agreement
application printing
area focus
bone
cancer
casting process
center
core area
custom
droplet
electricity
fabrication
feedback
focus MedTech
hospital
implant
jewelry
lab
market investment
material printing
point care
printer platform
procedure
process market
seasonality
side Slide
standard
thousand
trauma
venture
wax material
world application
year Slide
DDD Transcript
3D Systems Corporation (DDD) Q1 2026 Earnings Call Transcript
Positive5-12
The earnings call summary indicates strong financial performance with 11% YoY revenue growth and improved EBITDA, driven by robust growth in key sectors like Med Tech and Aerospace & Defense. Despite supply chain disruptions and economic risks, the company achieved positive EBITDA and improved margins. The Q&A section highlighted strategic expansions and product portfolio refreshes, indicating future growth potential. However, cautious guidance due to global volatility is noted. Overall, these factors suggest a positive sentiment, likely leading to a stock price increase in the 2% to 8% range.
3D Systems Corporation (DDD) Q4 2025 Earnings Call Transcript
Unknown3-9
The earnings call presents a mixed picture: while there's sequential revenue growth and positive developments in sectors like aerospace and defense, the overall year-over-year revenue declined by 9%. The company improved its EBITDA and reduced operating expenses, but gross margins were negatively impacted by a less favorable product mix. The Q&A revealed cautious guidance and some uncertainty, especially around consumer segments. Given these factors, the stock price is likely to remain stable with minor fluctuations, resulting in a neutral sentiment.
3D Systems Corporation (DDD) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call reflects a negative sentiment due to a significant revenue decline, reduced gross margins, and a net loss. Despite some cost-cutting improvements and new partnerships, the lack of clear guidance on achieving breakeven and the unclear management responses in the Q&A section contribute to investor uncertainty. The positive developments in the dental market and new partnerships are overshadowed by the overall financial performance and market concerns, leading to a likely negative stock price reaction.
3D Systems Corporation (DDD) Q2 2025 Earnings Call Transcript
Unknown8-12
The earnings call presents a mixed picture. The company's cost reduction and R&D investments are positive, but the withdrawal of 2025 guidance and uncertainty in capital spending are concerning. The dental market expansion, especially with the NextDent 300, shows promise, yet the aligner business decline and vague profitability timelines weigh negatively. The Q&A reveals cautious optimism, but management's unclear responses on some issues add uncertainty. Overall, the sentiment is neutral with no strong catalysts for a significant stock price move.
DDD Slides
DDD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
